UBS Group
YDES

UBS Group’s YD Bio Ltd YDES Stock Holding History

UBS Group’s Portfolio YDES Stock Details YDES Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$27.9K Buy
12,384
+756
+7% +$3.38K ﹤0.01% 7944
2026
Q1 		$89.5K Buy
11,628
+4,436
+62% +$42.8K ﹤0.01% 7052
2025
Q4 		$87.7K Sell
7,192
-3,124
-30% -$42.2K ﹤0.01% 6967
2025
Q3 		$201K Buy
+10,316
New +$179K ﹤0.01% 6668

Other funds holding YDES

GWAG
Garrett Wealth Advisory Group Weatherford, Texas $651M AUM 23.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CCMW
Cypress Capital Management (Wyoming) Sheridan, Wyoming $120M AUM 63.01% 1-Year Est. Return
Cerity Partners
Cerity Partners New York $82.7B AUM 28.53% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

UBS Group's YDES Position: Q2 2026 in Review

UBS Group increased its YD Bio Ltd (YDES) stake by 6.5% in Q2 2026, buying an estimated $3.38K and bringing the position to 12,384 shares worth $27.9K. The position accounts for ﹤0.01% of the portfolio, ranked #7944.

UBS Group first reported a position in YDES in Q3 2025 and has held it in 4 quarters since. The position peaked at $201K in Q3 2025. 12 funds tracked by Wall St. Rank hold YDES as of Q2 2026.

  • UBS Group held 12,384 shares of YD Bio Ltd worth $27.9K as of Q2 2026.
  • UBS Group bought 756 YD Bio Ltd shares in Q2 2026, an estimated $3.38K.
  • YD Bio Ltd made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #7944 holding.
  • UBS Group first reported a position in YD Bio Ltd in Q3 2025 and has held it in 4 quarters since.
  • UBS Group's YD Bio Ltd position peaked at $201K in Q3 2025.
  • 12 funds tracked by Wall St. Rank held YD Bio Ltd as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.